Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regression of Myocardial Steatosis by Nebivolol

NCT01358409 is registered in ClinicalTrials.gov with Lidia Szczepaniak as lead sponsor.

NCT NCT01358409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01358409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regression of Myocardial Steatosis by Nebivolol
Lead sponsor
Lidia Szczepaniak
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2011
Completion date
February 11, 2013
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac steatosis and lipotoxicity